Pharma & Bio
Lifestyle
The 'Data on Therapeutic Effects' Kim Seung-won Claimed to Have Seen… Turned Out Not to Be a Formal Research Paper
Kim Seung-won, the nominee for Minister of Justice, addressed the controversy surrounding the request for expedited processing of clinical trials for GenenCell’s COVID-19 treatment “ES16001,” explaini…
- 2026-09-10 08:02:03
- KIM JI-WAN
Technology
Hair-Loss Drug Hype Spreads to Korea as Hyundai Pharm and JW Shinyak Shares Soar [K-Bio Pulse]
(Image= ChatGPT)
On Sept. 8, shares of Hyundai Pharmaceutical and JW Shinyak extended their rallies as U.S. investor enthusiasm over next-generation hair-loss treatments spilled over into South Ko…
- 2026-09-10 07:31:05
- Minji Son
Technology
Amid Expectations for a New U.S. Hair Loss Drug… Even Korean Companies Selling Existing Drugs See ‘Thematic Surge’ [Bio Spotlight]
(Graphic: ChatGPT)
On the 8th, in the domestic pharmaceutical and biotech market, Hyundai pharm(004310)and JW SHINYAK CORPORATION(067290)continued their upward trend for consecutive days. As a U.S…
- 2026-09-10 07:31:02
- Minji Son
Technology
[K-Bio Pulse] Sky Labs Hits Limit-Up for the Second Consecutive Session
Korea’s pharmaceutical, biotech, and healthcare sectors saw heavy buying on the 13th, driven by a newly listed medical device company, a global drug theme, and U.S.-originated catalysts. With the KOSD…
- 2026-09-09 08:41:03
- Kim Seung-kwon
Technology
[Bio Spotlight] SkyLabs, Maker of 'Ring-Type Blood Pressure Monitor,' Rises Again… SAMIK PHARM. Co., LTD., Part of the Hair Loss Theme, Also Surges
On the 13th, the domestic pharmaceutical, biotech, and healthcare sectors saw strong buying momentum driven by a combination of expectations for explosive growth from newly listed medical device compa…
- 2026-09-09 08:41:02
- Kim Seung-kwon
Lifestyle
LNP: Essential for mRNA… Who Will Capture the 4 Trillion Won Manufacturing Market? [A Close Contest in K-Bio]
Following the application of the messenger RNA (mRNA) concept to COVID-19 vaccines—which have already been commercialized—and the emergence of results from a completely new type of “cancer vaccine,” a…
- 2026-09-09 08:26:02
- Kim Jinsoo
Technology
Coreline Soft Co., Ltd. Sees German Contracts Surge Sevenfold… High Expectations for Second-Half Earnings
Coreline Soft Co., Ltd.(384470)has secured 77 new medical institutions in Germany through July of this year. Compared to last year, when new contracts totaled only about 10 for the entire year, this r…
- 2026-09-09 08:07:02
- NA EUN-KYUNG
Technology
Kolon TissueGene, Inc.: Key Clinical Staff Member Resigns from TG-C Project... Aftermath of Phase 3 Clinical Trial Failure?
Kolon TissueGene, Inc.(950160)has decided to replace key personnel responsible for its U.S. clinical and regulatory affairs, drawing attention to the reasons behind this move. This personnel change is…
- 2026-09-09 07:52:02
- KIM SUNG-JIN
Technology
"From 140 mg to 280 mg"... G2GBIO, Inc. Solves the Puzzle of Dosage for Monthly Dementia Injection
#G2GBIO, Inc. has obtained new data on repeated administration of a high 280 mg dose of GB-5001, a once-monthly long-acting donepezil injection. Following the results of the 140 mg repeated-dose domes…
- 2026-09-08 14:02:01
- NA EUN-KYUNG
Lifestyle
Wise birds Inc. Is the ‘Only Listed Advertising Company to Exceed a 20% Operating Profit Margin’… Making a Quantum Leap with U.S. DTC Biotech
As the shadow of the economic downturn deepens and the advertising market remains frozen solid, the AI-based ad tech company Wise birds Inc.(273060)has become the only publicly listed advertising firm…
- 2026-09-08 10:01:02
- YU JIN-HEE
PHARM EDAILY
Shorts